
Stephen L. Rawlings
Examiner (ID: 18470, Phone: (571)272-0836 , Office: P/1643 )
| Most Active Art Unit | 1643 |
| Art Unit(s) | 1642, 1643, 1646 |
| Total Applications | 1483 |
| Issued Applications | 633 |
| Pending Applications | 153 |
| Abandoned Applications | 701 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7082670
[patent_doc_number] => 20050048050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth'
[patent_app_type] => utility
[patent_app_number] => 10/864818
[patent_app_country] => US
[patent_app_date] => 2004-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4195
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20050048050.pdf
[firstpage_image] =>[orig_patent_app_number] => 10864818
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/864818 | Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth | Jun 9, 2004 | Issued |
Array
(
[id] => 5655232
[patent_doc_number] => 20060140967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Immunogenic peptides for the treatment of prostate and breast cancer'
[patent_app_type] => utility
[patent_app_number] => 10/559329
[patent_app_country] => US
[patent_app_date] => 2004-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 22728
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0140/20060140967.pdf
[firstpage_image] =>[orig_patent_app_number] => 10559329
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/559329 | Immunogenic peptides for the treatment of prostate and breast cancer | Jun 1, 2004 | Issued |
Array
(
[id] => 7317566
[patent_doc_number] => 20040224347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Methods for identification, diagnosis, and treatment of breast cancer'
[patent_app_type] => new
[patent_app_number] => 10/858086
[patent_app_country] => US
[patent_app_date] => 2004-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11166
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224347.pdf
[firstpage_image] =>[orig_patent_app_number] => 10858086
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/858086 | Methods for identification, diagnosis, and treatment of breast cancer | May 31, 2004 | Abandoned |
Array
(
[id] => 7045105
[patent_doc_number] => 20050249700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling'
[patent_app_type] => utility
[patent_app_number] => 10/854000
[patent_app_country] => US
[patent_app_date] => 2004-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 19796
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20050249700.pdf
[firstpage_image] =>[orig_patent_app_number] => 10854000
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/854000 | Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling | May 24, 2004 | Abandoned |
Array
(
[id] => 7182919
[patent_doc_number] => 20040203012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Method of detecting and monitoring prostate and ovarian cancers'
[patent_app_type] => new
[patent_app_number] => 10/478333
[patent_app_country] => US
[patent_app_date] => 2004-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15448
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20040203012.pdf
[firstpage_image] =>[orig_patent_app_number] => 10478333
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/478333 | Method of detecting and monitoring prostate and ovarian cancers | May 20, 2004 | Abandoned |
Array
(
[id] => 7530560
[patent_doc_number] => 07842782
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-30
[patent_title] => 'Heparanase-derived peptides for vaccination of tumor patients'
[patent_app_type] => utility
[patent_app_number] => 10/557249
[patent_app_country] => US
[patent_app_date] => 2004-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 2
[patent_no_of_words] => 5565
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/842/07842782.pdf
[firstpage_image] =>[orig_patent_app_number] => 10557249
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/557249 | Heparanase-derived peptides for vaccination of tumor patients | May 17, 2004 | Issued |
Array
(
[id] => 7296248
[patent_doc_number] => 20040214289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Control of glycoforms in IgG'
[patent_app_type] => new
[patent_app_number] => 10/848421
[patent_app_country] => US
[patent_app_date] => 2004-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4382
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214289.pdf
[firstpage_image] =>[orig_patent_app_number] => 10848421
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/848421 | Control of glycoforms in IgG | May 17, 2004 | Abandoned |
Array
(
[id] => 6918050
[patent_doc_number] => 20050095611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Identification of biomarkers for detecting pancreatic cancer'
[patent_app_type] => utility
[patent_app_number] => 10/836649
[patent_app_country] => US
[patent_app_date] => 2004-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 29186
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20050095611.pdf
[firstpage_image] =>[orig_patent_app_number] => 10836649
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/836649 | Identification of biomarkers for detecting pancreatic cancer | Apr 29, 2004 | Abandoned |
Array
(
[id] => 7419182
[patent_doc_number] => 20040228871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Treatment and analysis of proliferative disorders'
[patent_app_type] => new
[patent_app_number] => 10/818906
[patent_app_country] => US
[patent_app_date] => 2004-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9353
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20040228871.pdf
[firstpage_image] =>[orig_patent_app_number] => 10818906
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/818906 | Treatment and analysis of proliferative disorders | Apr 4, 2004 | Abandoned |
Array
(
[id] => 7422078
[patent_doc_number] => 20040229260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Caspase-8 interacting proteins'
[patent_app_type] => new
[patent_app_number] => 10/814160
[patent_app_country] => US
[patent_app_date] => 2004-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 26809
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229260.pdf
[firstpage_image] =>[orig_patent_app_number] => 10814160
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/814160 | Caspase-8 interacting proteins | Mar 31, 2004 | Issued |
Array
(
[id] => 7230434
[patent_doc_number] => 20040156861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Melanoma associated peptide analogues and vaccines against melanoma'
[patent_app_type] => new
[patent_app_number] => 10/808681
[patent_app_country] => US
[patent_app_date] => 2004-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10825
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20040156861.pdf
[firstpage_image] =>[orig_patent_app_number] => 10808681
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/808681 | Melanoma associated peptide analogues and vaccines against melanoma | Mar 24, 2004 | Abandoned |
Array
(
[id] => 7286912
[patent_doc_number] => 20040146932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Prostate-specific gene, PCGEM1, and methods of using PCGEM1 to detect, treat, and prevent prostate cancer'
[patent_app_type] => new
[patent_app_number] => 10/802823
[patent_app_country] => US
[patent_app_date] => 2004-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 12091
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20040146932.pdf
[firstpage_image] =>[orig_patent_app_number] => 10802823
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/802823 | Prostate-specific gene, PCGEM1, and methods of using PCGEM1 to detect, treat, and prevent prostate cancer | Mar 17, 2004 | Abandoned |
Array
(
[id] => 7287037
[patent_doc_number] => 20040146978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Isolated human Ras-like proteins, nucleic acid molecules encoding human Ras-like proteins, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/800865
[patent_app_country] => US
[patent_app_date] => 2004-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 20779
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20040146978.pdf
[firstpage_image] =>[orig_patent_app_number] => 10800865
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/800865 | Isolated human Ras-like proteins, nucleic acid molecules encoding human Ras-like proteins, and uses thereof | Mar 15, 2004 | Abandoned |
Array
(
[id] => 7323514
[patent_doc_number] => 20040137455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Diagnosis of cancer or benign tumor using the aberrant expression product of the klk4 gene'
[patent_app_type] => new
[patent_app_number] => 10/473485
[patent_app_country] => US
[patent_app_date] => 2004-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 29931
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20040137455.pdf
[firstpage_image] =>[orig_patent_app_number] => 10473485
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/473485 | Diagnosis of cancer or benign tumor using the aberrant expression product of the klk4 gene | Mar 14, 2004 | Abandoned |
Array
(
[id] => 274066
[patent_doc_number] => 07560230
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-14
[patent_title] => 'Method for determining susceptibility of tumor to treatment with anti-neoplastic agent'
[patent_app_type] => utility
[patent_app_number] => 10/546612
[patent_app_country] => US
[patent_app_date] => 2004-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21703
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/560/07560230.pdf
[firstpage_image] =>[orig_patent_app_number] => 10546612
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/546612 | Method for determining susceptibility of tumor to treatment with anti-neoplastic agent | Mar 3, 2004 | Issued |
Array
(
[id] => 7264810
[patent_doc_number] => 20040151725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'CTLA-4 immunoglobulin fusion proteins having modified effector functions and uses therefor'
[patent_app_type] => new
[patent_app_number] => 10/792637
[patent_app_country] => US
[patent_app_date] => 2004-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 24514
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20040151725.pdf
[firstpage_image] =>[orig_patent_app_number] => 10792637
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/792637 | CTLA-4 immunoglobulin fusion proteins having modified effector functions and uses therefor | Mar 1, 2004 | Abandoned |
Array
(
[id] => 7275617
[patent_doc_number] => 20040235068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders'
[patent_app_type] => new
[patent_app_number] => 10/488033
[patent_app_country] => US
[patent_app_date] => 2004-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 30969
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235068.pdf
[firstpage_image] =>[orig_patent_app_number] => 10488033
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/488033 | Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders | Feb 26, 2004 | Abandoned |
Array
(
[id] => 1077107
[patent_doc_number] => 07615623
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-10
[patent_title] => 'BAG proteins and nucleic acid molecules encoding them'
[patent_app_type] => utility
[patent_app_number] => 10/782627
[patent_app_country] => US
[patent_app_date] => 2004-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 31
[patent_no_of_words] => 10870
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/615/07615623.pdf
[firstpage_image] =>[orig_patent_app_number] => 10782627
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/782627 | BAG proteins and nucleic acid molecules encoding them | Feb 17, 2004 | Issued |
Array
(
[id] => 5153836
[patent_doc_number] => 20070036719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Prostate cancer diagnosis and treatment'
[patent_app_type] => utility
[patent_app_number] => 10/543572
[patent_app_country] => US
[patent_app_date] => 2004-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12915
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20070036719.pdf
[firstpage_image] =>[orig_patent_app_number] => 10543572
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/543572 | Prostate cancer diagnosis and treatment | Jan 27, 2004 | Issued |
Array
(
[id] => 7675311
[patent_doc_number] => 20040126807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Compositions and methods for the diagnosis and treatment of tumor'
[patent_app_type] => new
[patent_app_number] => 10/758377
[patent_app_country] => US
[patent_app_date] => 2004-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 46103
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0126/20040126807.pdf
[firstpage_image] =>[orig_patent_app_number] => 10758377
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/758377 | Compositions and methods for the diagnosis and treatment of tumor | Jan 14, 2004 | Abandoned |